Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke

Lifelong treatment with antiplatelet drugs is recommended following a transient ischemic attack or ischemic stroke. Bleeding complications may offset the benefit of antiplatelet drugs in patients at increased risk of bleeding and low risk of recurrent ischemic events. We aimed to investigate the net...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilkens, Nina A., Algra, Ale, Diener, Hans Christoph, Bath, Philip M., Csiba, László, Hacke, Werner, Kappelle, L. Jaap, Koudstaal, Peter J., Leys, Didier, Mas, Jean-Louis, Sacco, Ralph L., Greving, Jacoba P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478107/
https://www.ncbi.nlm.nih.gov/pubmed/34304604
http://dx.doi.org/10.1161/STROKEAHA.120.031755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478107/
https://www.ncbi.nlm.nih.gov/pubmed/34304604
http://dx.doi.org/10.1161/STROKEAHA.120.031755

Ejemplares similares